Publication | Open Access
Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation
73
Citations
30
References
2017
Year
TQ inhibits LoVo cancer cell growth and migration, and this result highlights the therapeutic advantage of using TQ in combination therapy against colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1